Cardlytics has appointed Chris Cheng as chief legal officer, effective 3 August 2026. Cheng will oversee the company's legal and compliance organisation and serve on the leadership team. Cheng brings over 20 years of legal leadership experience from high-growth technology companies, including senior roles at Zoom, Uber, Upwork, and eBay. He most recently served as chief legal officer and corporate secretary at Iterable. "His background spanning some of the most dynamic companies in technology, combined with his sound business judgment and collaborative approach, make him the right partner as we execute our next chapter," said Amit Gupta, chief executive officer of Cardlytics. Cheng replaces former chief legal officer Nick Lynton, who departed in July 2026.

Lake Street has reduced its price target on Cardlytics, Inc. (NASDAQ:CDLX) to $1.25 from $1.50 whilst maintaining a Hold rating, following the company's first-quarter guidance and ongoing uncertainty from recent business changes. Cardlytics reported first-quarter 2026 results showing revenue of $34.3 million, down 39% year-over-year. Billings fell 37% to $58.1 million, whilst adjusted contribution declined 28% to $19.7 million. Net loss narrowed to $4.5 million, or $0.08 per diluted share, from $13.3 million the previous year. Monthly qualified users decreased 8% to 197 million, with average contribution per user falling to $0.10 from $0.13. The commerce media company partners with banks to deliver targeted advertisements using first-party card transaction data.

Cardlytics (NASDAQ: CDLX) legal chief plans exit with $380,000 severance. Filing Impact (Moderate) Filing Sentiment Rhea-AI Filing summary. Cardlytics, Inc. disclosed that Chief Legal and Privacy Officer Nick Lynton has notified the company of his intent to resign, effective on the earlier of his successor's appointment or the close of business on July 3, 2026. Under a new Transition Agreement dated May 10, 2026, he will continue in his role, and if a successor is appointed before the effective date, he will serve in a non-officer advisory capacity through that date while maintaining his current salary and benefits. After his employment ends, subject to compliance with the agreement and execution of a separate Release Agreement, Cardlytics will pay a lump-sum separation payment of $380,000, reimburse COBRA premiums for up to twelve months, and provide an additional lump-sum payment of $70,320.21, which is expected to be paid in the first quarter of 2027. 8-K event classification. Item 5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Key figures. Resignation effective date: July 3, 2026 Primary separation payment: $380,000 Additional lump-sum payment: $70,320.21 +2 more Key terms. Transition Agreement, COBRA premiums, Release Agreement, restrictive covenants, +1 more 05/12/2026 - 01:10 PM